Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07725250) titled 'Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial' on July 21.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: National Bureau of Economic Research, Inc.
Condition:
Hypertension
Intervention:
Other: Digital heath tool
Other: Low-intensity recommendation
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: April 10, 2026
Target Sample Size: 3000
Countries of Recruitment:
United States...